#DYK? As a pharma industry expert, you have the power to amplify your impact on the future of medicine and global #PublicHealth. When you become a US Pharmacopeia Expert Volunteer, your experience and perspective will contribute to quality standards that accelerate drug development, enhance manufacturing efficiency, and reduce barriers to ensuring quality and regulatory compliance. Don’t miss the opportunity to create meaningful global change as part of the #USPExpertVolunteer network during our next five-year cycle. Apply today and put your passion, commitment, and scientific rigor into action as a Member or Chair with a USP Expert Committee in 2025-2030: Bit.ly/USPExpertVolunteer
关于我们
US Pharmacopeia (USP) is an independent, scientific nonprofit organization that has focused on building trust in the supply of safe, quality medicines since 1820. We are a public health organization that uses rigorous science and public quality standards setting to protect patient safety and improve global health. We are committed to building public trust and confidence in drug therapies to enable people to live longer and healthier, and also work to building trust in dietary supplements and food ingredients. Currently, we are working to strengthen the global supply chain so that the medicines people rely on are available when needed and work as expected. Our Volunteers USP standards are in a continuous process of review and revision based upon new evidence, emerging public health concerns, and public requests for revision. Input from our volunteers, through our Council of Experts and Expert Committees and Panels, is crucial for maintaining our standards and preserving public trust. Our Governing Bodies The USP Convention helps guide our areas of impact – nearly 500 Member Organizations from around the world contribute valuable perspectives, experiences, and expertise from across healthcare and science. In addition to collaborating on critical healthcare and science matters, every five years, Convention Members adopt USP Resolutions and elect USP’s Board of Trustees and the Council of Experts who lead USP’s standards-setting Expert Committees. Visit www.usp.org to learn more.
- 网站
-
http://www.usp.org
US Pharmacopeia的外部链接
- 所属行业
- 制药业
- 规模
- 1,001-5,000 人
- 总部
- Rockville,Maryland
- 类型
- 非营利机构
- 创立
- 1820
- 领域
- Product Quality–Standards and Verification、Healthcare Information、pharmaceuticals、Medicines quality、medicines safety、substandard medicines、falsified medicines、Medicines Supply Chain、COVID-19 Vaccines、Pharmaceuticals Advanced Manufacturing和Pharmaceuticals Continuous Manufacturing
地点
US Pharmacopeia员工
-
Shelley Whiddon
Building and implementing strategic initiatives that engage stakeholders and achieve results
-
Scott Bolgiano
Senior Manager, Publishing Technology at USP, the United States Pharmacopeia
-
Melanie Vipond
Senior Talent Acquisition Partner
-
Stu Kim
Legal Counsel - Pharmaceutical at Catalyst Pharmaceuticals, Inc.
动态
-
Attending Developing Countries Vaccine Manufacturers Network (DCVMN International)'s Annual General Meeting next week? Don’t miss USP’s session where USP's Laura B. Martin, PhD and Afrigen Biologics (Pty) Ltd’s Petro Terblanche will discuss regulatory challenges faced by vaccine manufacturers in LMICs, highlighting experiences from African manufacturers. This session will also explore ways to build regulatory capacity for vaccine approval for market use. USP will also be presenting alongside other global health experts in a session to highlight new vaccine technologies, including novel applications in mRNA manufacturing and vaccine delivery. Kevin Carrick will highlight the role of quality standards for manufacturers and regulators that support quality-assured manufacturing, packaging, and release processes for vaccines. If you’ll be in Sao Paulo for #AGM2024, be sure to connect with our team to learn how USP is working to expand access to quality-assured vaccines and biologics. Learn more: https://ow.ly/NlFG50TGICj
-
As we prepare to celebrate #WorldStandardsDay 🎉 next week, we thank all who help make our system one worth celebrating. The U.S. regulatory system sets the bar globally so that patients receive safe, quality medicines. Trust in our medicines supply chain is earned daily through FDA’s rigorous oversight, industry commitment to and investment in quality, and adherence to US Pharmacopeia public quality standards. The USP-FDA relationship dates back to the 1906 Pure Food and Drug Act, which deemed the United States Pharmacopeia and the National Formulary official compendia under federal law. Scroll ⤵️ to see how USP and FDA work together to help make sure that U.S. medicines are among the safest in the world. Join us in celebrating with a #Repost to spread the word and learn more: Bit.ly/FDAandUSP #FDA #Collaboration #Standards
-
Strong regulatory systems are critical to improving access to safe, quality-assured medical products. With support from Bill & Melinda Gates Foundation, we're excited to work with Food and Drugs Authority,Ghana to develop a continental training hub for regulators across #Africa. Learn more about the project ➡: https://ow.ly/x6B950TGR5B
-
Jazz Pharmaceuticals is sponsoring a RAPS Philadelphia Chapter event - a rare in-person opportunity to attend a session with both FDA and US Pharmacopeia onsite in our Philadelphia office at 20th and Market - on October 22 about Putting FDA Consensus and USP Standards to Work to Streamline Reviews. You do not need to be a Regulatory Affairs Professionals Society (RAPS) member to attend-registration link below). Standards and conformity assessment including eSTAR program and ASCA along with how to leverage this information for submissions will be covered. This discussion is applicable for all areas of regulatory as applies to combination products and delivery systems as well as devices. Food will be provided and we look forward to seeing you there. Further information is in the link below and encourage to register as will fill up quickly. The $15 member/$20 nonmember fee collected during registration goes to the RAPS Philadelphia Chapter for future networking events, feel free to reach out if any questions. Speakers: & Stacy Cho, FDA Elizabeth Besteder Bladen, MS, MA, MLIS, https://lnkd.in/epFYPQ_G #RAPS #FDA #USP Jonas Wilf Amanda Pentecost, Ph.D., RAC Steven Truong Krishna Dave Venkat Reddy Kumbam-MS, RAC Jody Gould Allison Radwick
-
At USP, we recognize the growing momentum of continuous manufacturing and the need for comprehensive information to help pharmaceutical manufacturers make informed decisions. Our Continuous Manufacturing Knowledge Center is here to bridge that gap. In this video, you’ll learn how our Continuous Manufacturing Knowledge Center provides extensive resources and research as well as discussion forums that are designed for all levels of expertise, accessible anytime, anywhere. Visit cmkc.usp.org to access a wealth of information, engage with peers, and stay informed. #ContinuousManufacturing #USPScience
-
Join USP at American Association of Pharmaceutical Scientists (AAPS) | @aapscomms 2024 PharmSci360, the premier event for pharmaceutical scientists that brings together experts from industry, academia, and regulatory bodies! This year's conference promises to be an unparalleled opportunity for exploring cutting-edge research, innovative technologies, and critical challenges in drug development and manufacturing. USP participation highlights include presentations on emerging standards for novel excipients and their impact on drug development, discussions on the multi-attribute method (MAM) for biopharmaceutical quality control, insights into risk mitigation in pharmaceutical quality through reference standards, and sessions on collaborative training initiatives for strengthening regulatory and laboratory systems globally. PharmSci360 offers a unique platform to engage with USP experts, learn about the latest quality standards, and contribute to advancing global health through pharmaceutical innovation. We are excited to be part of the conversations shaping the future of drug discovery, development, and delivery. Don't miss this opportunity to network with peers, explore groundbreaking research, and address critical industry challenges. We look forward to seeing you at AAPS 2024 PharmSci360 and working together to drive the future of pharmaceutical sciences forward. Register below! ⤵ #AAPS #PharmSci360
此处无法显示此内容
在领英 APP 中访问此内容等
-
Stop by and see us at #CPHIMilan October 8-10! USP’s team of experts will be at Booth 4C113 ready to chat with you about how our innovative quality solutions can help your company keep up in the fast-changing global healthcare landscape.
-
⏰ iRelaunch #ReturnToWork Conference | Oct. 8-10, 2024 ⏰ Tap into your pharmaceutical sciences expertise and join the #ReLaunchers to re-enter, transition, or propel your career to the next level. But, don’t take our word for it! USP Expert Volunteer Giovan Lane ⤵️ underscores how your unique and diverse perspective can help pave your professional path all while make a meaningful, lasting impact on global public health. Register: Bit.ly/iRelaunch-USP for your chance to attend the #iRelaunch Conference that will… 🚀be your ultimate guide to preparing for a successful relaunch and landing the job you want! 🚀 connect with employers actively hiring relaunchers at their virtual job fair, and hear directly from senior leaders and program managers about why they value relaunchers. 🚀 get top-tier job search advice from expert coaches, and listen to candid stories from relaunchers who successfully returned to the workforce. #ReturnToWork #ProudToBeUSP #CareerEvent #USPExpertVolunteer
-
USP looks forward to working with Phlow to establish quality methods for advanced manufacturing of active pharmaceutical ingredients (APIs) for the development of medical countermeasures within this interagency partnership. Increasing domestic manufacturing capacity and supply of APIs enhances Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense-JPEO-CBRND, U.S. Department of Health and Human Services (HHS), and HHS Administration for Strategic Preparedness and Response (ASPR) rapid response capabilities to ensure effective emergency response in counteracting chemical and biological threats. Learn more about USP solutions to strengthen domestic supply chain security: https://ow.ly/YgAP50TCtPW
We are thrilled to start work on an interagency partnership to begin domestic manufacturing of critical ingredients for medical countermeasure drug products that support the joint force and its allies in counteracting chemical and biological threats with the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense-JPEO-CBRND and U.S. Department of Health and Human Services (HHS), HHS Administration for Strategic Preparedness and Response (ASPR). "We are pleased to partner with the JPEO-CBRND on this effort to further strengthen this critical infrastructure in the United States for civilians and soldiers alike," said Arlene Joyner, Deputy Assistant Secretary Director, Office of Industrial Base Management and Supply Chain HHS Administration for Strategic Preparedness and Response We extend our deepest gratitude to ASPR's Office of Industrial Base Management and Supply Chain (IBMSC), U.S Senator Tim Kaine, U.S. Senator Mark Warner, and other esteemed congressional leaders for their unwavering support of Phlow's mission and this critical initiative, which is integral to the United States National Defense Strategy. This is truly a momentous occasion for the future healthcare of our warfighters as we work to provide a layered defense against threats. Read the full release: https://lnkd.in/e-4W9f78